Print Share Email Twitter Facebook Linkedin Reddit Get Citation Citation Disclaimer: These citations have been automatically generated based on the information we have and it may not be 100% accurate. Please consult the latest official manual style if you have any questions regarding the format accuracy. AMA Citation Mitrani LR, Koruth J. Mitrani L.R., & Koruth J Mitrani, Lindsey R., and Jacob Koruth. A Multicenter, RandomiZed, Active-ControLled Study to Evaluate the Safety and Tolerability of Two Blinded Doses of Abelacimab Compared With Open-Label Rivaroxaban in Patients With Atrial Fibrillation - AZALEA-TIMI 71. Hurst's the Heart Updates, 20 December 2023. McGraw Hill, 2023. AccessMedicine. https://accessmedicine.mhmedical.com/updatesContent.aspx?gbosid=644184§ionid=284371678APA Citation Mitrani LR, Koruth J. Mitrani L.R., & Koruth J Mitrani, Lindsey R., and Jacob Koruth. (2023). A multicenter, randomized, active-controlled study to evaluate the safety and tolerability of two blinded doses of abelacimab compared with open-label rivaroxaban in patients with atrial fibrillation - azalea-timi 71. Fuster V. Fuster V Fuster, Valentin. [publicationyear2] Hurst's the heart updates. McGraw Hill. https://accessmedicine.mhmedical.com/updatesContent.aspx?gbosid=644184§ionid=284371678.MLA Citation Mitrani LR, Koruth J. Mitrani L.R., & Koruth J Mitrani, Lindsey R., and Jacob Koruth. "A Multicenter, RandomiZed, Active-ControLled Study to Evaluate the Safety and Tolerability of Two Blinded Doses of Abelacimab Compared With Open-Label Rivaroxaban in Patients With Atrial Fibrillation - AZALEA-TIMI 71." Hurst's the Heart Updates Fuster V. Fuster V Fuster, Valentin. McGraw Hill, 2023, https://accessmedicine.mhmedical.com/updatesContent.aspx?gbosid=644184§ionid=284371678. Download citation file: RIS (Zotero) EndNote BibTex Medlars ProCite RefWorks Reference Manager Mendeley © Copyright Tools Annotate Clip Autosuggest Results Your Access profile is currently affiliated with [InstitutionA] and is in the process of switching affiliations to [InstitutionB]. Please select how you would like to proceed. Keep the current affiliation with [InstitutionA] and continue with the Access profile sign in process Switch affiliation to [InstitutionB] and continue with the Access profile sign in process Get Free Access Through Your Institution Learn how to see if your library subscribes to McGraw Hill Medical products. Subscribe: Institutional or Individual Sign In Error: Incorrect UserName or Password Username Error: Please enter User Name Password Error: Please enter Password Sign in Forgot Password? Forgot Username? Download the Access App: iOS | Android Sign in via OpenAthens Sign in via Shibboleth You already have access! Please proceed to your institution's subscription. Create a free profile for additional features.